Get In Touch with RyboDyn
Please tell us a little bit about yourself and why you'd like to get connected. RyboDyn + SOSV will follow up with you via email.
RyboDyn uses RyboCypher™ to decode the dark transcriptome and dark proteome, revealing hidden, disease-specific protein targets overlooked by conventional sequencing. Its AI models predict cryptic proteins from non-coding RNAs and generate Cryptic Targets™ for antibody-based immunotherapies. Validated discoveries are translated into first-in-class, off-the-shelf drug candidates aimed at unmet cancer needs.
The entire immuno-oncology field is orbiting around the same 30 targets and are hungry for new ones
Our genome makes RNA molecules that current sequencing technologies cannot detect. These molecules encode undiscovered human proteins (the dark proteome), providing an untapped source of disease-specific protein targets that will become foundational to the future of precision medicine
Please tell us a little bit about yourself and why you'd like to get connected. RyboDyn + SOSV will follow up with you via email.
No Offer, Solicitation, Advice, or Recommendation
Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.